Search
Search Funnelback University
11 -
20 of
35
search results for `Lupus treatment`
Fully-matching results
-
Ken Smith wins Lupus Research Institute Distinguished Innovator Award …
https://www.immunology.cam.ac.uk/news/lriaward23 Feb 2024: A complex autoimmune disease, lupus affects approximately five million people worldwide, primarily women. ... Potential for Personalized Treatment. Dr. Smith's group has discovered that lupus patients who develop more severe disease have a distinctive -
Concerns over medical consultations by phone and video – study |…
https://www.cam.ac.uk/research/news/concerns-over-medical-consultations-by-phone-and-video-study2 Nov 2021: The majority of patients were from the UK (96%) and had inflammatory arthritis (32%) or lupus (32%). ... There was concern, too, that telemedicine increased the potential for inequalities in treatment. -
Dr David Jayne | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/jayne23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis. -
LMB In The News - Page 73 of 87 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-in-the-news/page/73/New drug Benlysta in Lupus treatment. ... Published on. 15 June, 2011. “Benlysta emerges as a direct approach in lupus treatment. -
Professor David Jayne - Experimental Medicine and Immunotherapeutics…
https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/23 Feb 2024: Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. -
LMB News - Page 78 of 83 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-news/page/78/for treatment of lupus. ... Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems. -
https://www.phpc.cam.ac.uk/pcu/tag/lupus/feed/
https://www.phpc.cam.ac.uk/pcu/tag/lupus/feed/19 Feb 2024: u/u/p pemI feel that she [/emrheumatologistem] doesn’t care about me and so I no longer care about my lupus treatment and medication either. ... fatigue, pain, cognitive impairment and others, have received very limited support, treatment or -
LMB News - Page 83 of 83 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-news/page/83/Human Antibodies developed for Treatment of Lupus and Anthrax. ... treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism. -
History of medicine timeline: 1473 to now | St Catharine's…
https://www.caths.cam.ac.uk/about-us/history/550/medicine2022: Fellow Prof. Rahul Roychoudhuri signs a partnership with AstraZeneca to advance the treatment of lupus. -
Dr Frances Hall | Sidney Sussex College Cambridge
https://www.sid.cam.ac.uk/people/dr-frances-hallRituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.